Medicamen Organics Ltd - Stock Valuation and Financial Performance

BSE: 0 | NSE: MEDIORG | Pharmaceuticals & Drugs | Small Cap

BSE Share Price
Not Listed

DeciZen - make an informed investing decision on Medicamen Organics

Overall Rating
M-Cap below 500cr. High Risk from low Liquidity Bole Toh

1. Quality

2. Valuation

Undervalued

3. Price Trend

Medicamen Organics stock performance -

mw4me loader
P/E Ratio (SA):
70.96
Market Cap:
170.6 Cr.
52-wk low:
0
52-wk high:
0

Is Medicamen Organics Ltd an attractive stock to invest in?

1. Is Medicamen Organics Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Medicamen Organics Ltd is a below average quality company.

2. Is Medicamen Organics Ltd undervalued or overvalued?

The key valuation ratios of Medicamen Organics Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

3. Is Medicamen Organics Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Medicamen Organics Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Medicamen Organics:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Medicamen Organics Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
ROCE % 3.7%2.5%7.2%11.8%-
Value Creation
Index
-0.7-0.8-0.5-0.2-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 25.12122.225.325
Sales YoY Gr.--16.3%5.6%14.1%-
Adj EPS 0.50.21.62.82.1
YoY Gr.--66%858.8%71.2%-
BVPS (₹) 12.513.41517.722
Adj Net
Profit
0.30.112.42
Cash Flow from Ops. -1.20-0.6-3.7-
Debt/CF from Ops. -8.2274-20.2-3.4-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA0.3%14.1%
Adj EPS NANA77.4%71.2%
BVPSNANA12.4%18%
Share Price - - - -

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
41.311.519.910.3
Op. Profit
Mgn %
6.55.78.518.8NAN
Net Profit
Mgn %
1.20.54.49.59.5
Debt to
Equity
1.31.31.30.8-
Working Cap
Days
02603053520
Cash Conv.
Cycle
053801500

Recent Performance Summary

Net Profit is growing at healthy rate in last 3 years 77.37%

Debt to equity has declined versus last 3 years average to 0.83

Return on Equity has declined versus last 3 years average to 10.30%

Sales growth has been subdued in last 3 years 0.29%

Sales growth is not so good in last 4 quarters at 0.00%

Latest Financials - Medicamen Organics Ltd.

Standalone Consolidated
TTM EPS (₹) 2.1 -
TTM Sales (₹ Cr.) 25.3 -
BVPS (₹.) 22 -
Reserves (₹ Cr.) 14 -
P/BV 6.63 -
PE 70.96 -
From the Market
52 Week Low / High (₹) 0.00 / 0.00
All Time Low / High (₹) - / -
Market Cap (₹ Cr.) 171
Equity (₹ Cr.) 11.7
Face Value (₹) 10
Industry PE 42

Management X-Ray of Medicamen Organics:

Shareholding Pattern

No Data To Display

Promoter's Holding & Share Pledging

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Medicamen Organics

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24
Sales25212225
Operating Expenses 23202021
Manufacturing Costs61067
Material Costs136109
Employee Cost 2233
Other Costs 2222
Operating Profit 2125
Operating Profit Margin (%) 6.5%5.7%8.4%18.7%
Other Income 0010
Interest 0011
Depreciation 1111
Exceptional Items 0000
Profit Before Tax 0013
Tax 0001
Profit After Tax 0012
PAT Margin (%) 1.2%0.5%4.4%9.5%
Adjusted EPS (₹)0.50.21.62.8
Dividend Payout Ratio (%)0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund 78915
Share Capital 6669
Reserves 1237
Minority Interest0000
Debt9101112
Long Term Debt1100
Short Term Debt891112
Trade Payables7797
Others Liabilities 3234
Total Liabilities 26283339

Fixed Assets

Gross Block16161717
Accumulated Depreciation4567
Net Fixed Assets11111110
CWIP 0000
Investments 0000
Inventories3566
Trade Receivables861117
Cash Equivalents 1011
Others Assets4545
Total Assets 26283339

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity -10-1-4
PBT 0013
Adjustment 2112
Changes in Working Capital -3-1-2-8
Tax Paid 0000
Cash Flow From Investing Activity 0-100
Capex 0-100
Net Investments 0000
Others 0000
Cash Flow From Financing Activity 1014
Net Proceeds from Shares 0002
Net Proceeds from Borrowing 0000
Interest Paid 00-1-1
Dividend Paid 0000
Others 2123
Net Cash Flow 0000
PARTICULARSMar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)3.991.3111.4119.9
ROCE (%)5.674.1310.1116.6
Asset Turnover Ratio0.950.780.740.71
PAT to CFO Conversion(x)N/AN/A-1-2
Working Capital Days
Receivable Days110120140198
Inventory Days39649089
Payable Days203463299320

Medicamen Organics Ltd Stock News

Medicamen Organics Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Medicamen Organics on 01-Jan-1970 05:30 is ₹0.00.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 01-Jan-1970 05:30 the market cap of Medicamen Organics stood at ₹170.6.
The latest P/E ratio of Medicamen Organics as of 01-Jan-1970 05:30 is 70.96.
The latest P/B ratio of Medicamen Organics as of 01-Jan-1970 05:30 is 6.63.
The 52-week high of Medicamen Organics is ₹0.00 and the 52-week low is ₹0.00.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Medicamen Organics is ₹25.27 ( Cr.) .

About Medicamen Organics Ltd

Medicamen Organics Limited was incorporated on March 15, 1995 as ‘Panchdeep Pharmaceuticals Limited’, a public limited company under the Companies Act, 1956, pursuant to a certificate of incorporation dated March 15, 1995 issued by the Registrar of Companies, National Capital Territory (NCT) of Delhi and Haryana. The company has received Certificate of Commencement of Business on March 15, 1995, issued by the Registrar of Companies, National Capital Territory (NCT) of Delhi and Haryana. Subsequently, pursuant to a resolution passed by the Board of Directors in their meeting held on July 31, 1995 and by the Shareholders in their EGM held on October 14, 1995, the name of the Company was changed to ‘Medicamen Organics Limited’ and a fresh certificate of incorporation dated November 14, 1995 was issued by the Registrar of Companies, Delhi and Haryana at Delhi.

Medicamen Organics is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer. It markets its product to private pharma companies in domestic as well as international markets through third party distributors or on loan license basis. Its products are marketed across India as well as African, CIS and south East Asian Countries like Congo, Benin, Cameg, Togo, Senegal, Burkina Faso, Philippines, Myanmar, Mozambique, Togo, Burundi, Kyrgyzstan and Kenya by its third-party distributor.

Its manufacturing facilities are capable of producing pharmaceutical formulations and products and has fully equipped quality control department with experienced and qualified staff to facilitate smooth manufacturing process. It has in-house testing laboratory and necessary infrastructure to test its raw materials and finished products to match the quality standards. Its core strength lies in product development and documentation, it is regularly engaged in research and development and launching new products. This gives it an exhaustive product list as well as fair pricing in the market. Its product portfolio consists of comprises of wide range of drugs like, Anti-Bacterial, Anti Diarrheal, Anti-Fungal, Anti-Malarial, Anti Diabetic, Proton Pump Inhibitor, Anti Histamine, Anti-Hypertensive drugs, Anti Lipidemic Drug, Anti Parasitic, Multivitamin, Multimineral and Nonsteroidal anti-inflammatory drug (NSAIDS).

Business area of the company

The company is engaged in developing, manufacturing and distribution of broad range of pharmaceutical dosage including generic dosage in form of Tablets, Capsules, Oral Liquids, Ointments, Gel, Syrups, Suspension and Dry powders for government (including both state and central governments) and private institutions as contract manufacturer / third party manufacturer.

Products category

  • Capsules
  • Ointment/external preparation
  • Suspension
  • Dry powder sachet
  • Tablet

Awards and accreditations

  • 2015: ISO 9001:2015 - Manufacture and Supply of Food Supplement for Human use and Non Beta Lactum Tablets, Capsules, Liquid and Ointments (Unit II). 
  • 2015: ISO 9001: 2008 Manufacture and Supply of Food Supplement for Human Use (Unit II). 
  • 2010: ISO 9001: 2008 (Quality Management System). 
  • 2018. ISO 9001:2015 certified company (Unit I) Manufacture and Supply of Tablets, Capsules and Liquid Orals for both Domestic and Export Market.

History and milestones

  • 1995: The company was incorporated as a Public Limited company under the name ‘Panchdeep Pharmaceuticals Limited’ and later the company has changed its name from ‘Panchdeep Pharmaceuticals Limited’ to ‘Medicamen Organics Limited’.
  • 1996: It started with trading of pharmaceuticals for supplies to various Government departments.
  • 1998-2007: It took loan license with ‘M/s Rhydurg Pharmaceuticals’, a unit situated in Kundali across the border of Delhi and started getting product manufactured for its marketing.
  • 2007: It purchased a plot of land measuring 1200 square meter from SIDCUL Industrial Authority in Haridwar and started construction for its own pharma unit. The construction of three-storeyed building (including basement measuring 15000 sq. feet was completed and it got its own manufacturing license for tablets, capsules, oral liquids in form 25 and 28 and started its owns production in the same year (UNIT-I).
  • 2007: It received WHO/GMP Certificate for Unit I.
  • 2010: It applied for a license for manufacturing of food supplements, like protein powders, vitamin tablets and syrups etc. and got its first license.
  • 2017: It received WHO/GMP Certificate for Unit I.
  • 2017: It got an opportunity to purchase one readymade adjacent unit to shift its food production in a separate unit. It got its first license in this Unit and tied up with renowned Pharma company for one of their renowned products for manufacturing in its plant. This unit was termed as (UNIT-II).
  • 2017: It stopped production of general pharma products in Unit-I and converted it into a unit for exclusive production of Iron Tablets because of its huge world-wide demand.

Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.